RECRUITINGOBSERVATIONAL
Risk Factors for Stroke or Systemic Embolism in Chinese Patients with Non-Valvular Atrial Fibrillation Registry
About This Trial
This study is aimed to validate the existing stroke risk stratification model for patients with atrial fibrillation (AF) (CHA2DS2-VASc Score, CHADS2 Score, ATRIA score, ABC score, etc.) and establish a new stroke risk assessment model using a nationwide AF -specific registry in China.
Who May Be Eligible (Plain English)
Who May Qualify:
- 18 years of age or older; male or female.
- History of documented atrial fibrillation.
- Able to provide written willing to sign a consent form.
Who Should NOT Join This Trial:
- Subjects with moderate or severe mitral stenosis or a mechanical heart valve
- Subjects with previous or planned AF ablation.
- Subjects with previous or planned left atrial appendage closure.
- Subjects unable to cooperate with follow-up after assessment.
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* 18 years of age or older; male or female.
* History of documented atrial fibrillation.
* Able to provide written informed consent.
Exclusion Criteria:
* Subjects with moderate or severe mitral stenosis or a mechanical heart valve
* Subjects with previous or planned AF ablation.
* Subjects with previous or planned left atrial appendage closure.
* Subjects unable to cooperate with follow-up after assessment.
Locations (1)
Fuwai Hospital, CAMS & PUMC
Beijing, Beijing Municipality, China